Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

CASI

CASI Pharmaceuticals (CASI)

CASI Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CASI
日付受信時刻ニュースソース見出しコード企業名
2025/01/2122 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CASICASI Pharmaceuticals Inc
2025/01/0214 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CASICASI Pharmaceuticals Inc
2024/12/2622 : 30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CASICASI Pharmaceuticals Inc
2024/12/2406 : 16Edgar (US Regulatory)Form F-3/A - Registration statement by foreign private issuers: [Amend]NASDAQ:CASICASI Pharmaceuticals Inc
2024/12/2107 : 26Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:CASICASI Pharmaceuticals Inc
2024/12/1622 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CASICASI Pharmaceuticals Inc
2024/11/1522 : 30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CASICASI Pharmaceuticals Inc
2024/09/1220 : 30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CASICASI Pharmaceuticals Inc
2024/09/0421 : 00PR Newswire (US)CASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCENASDAQ:CASICASI Pharmaceuticals Inc
2024/09/0413 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CASICASI Pharmaceuticals Inc
2024/08/2921 : 00Edgar (US Regulatory)Form F-3/A - Registration statement by foreign private issuers: [Amend]NASDAQ:CASICASI Pharmaceuticals Inc
2024/08/1706 : 01Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:CASICASI Pharmaceuticals Inc
2024/08/1621 : 30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CASICASI Pharmaceuticals Inc
2024/08/1621 : 00PR Newswire (US)CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2024 BUSINESS AND FINANCIAL RESULTSNASDAQ:CASICASI Pharmaceuticals Inc
2024/08/1419 : 18Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CASICASI Pharmaceuticals Inc
2024/07/2006 : 30PR Newswire (US)CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTASNASDAQ:CASICASI Pharmaceuticals Inc
2024/07/1919 : 07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CASICASI Pharmaceuticals Inc
2024/07/1605 : 01Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:CASICASI Pharmaceuticals Inc
2024/07/0820 : 48Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CASICASI Pharmaceuticals Inc
2024/07/0820 : 30PR Newswire (US)CASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVPNASDAQ:CASICASI Pharmaceuticals Inc
2024/06/2705 : 15PR Newswire (US)CASI Pharmaceuticals Announces Plan To Submit IND Application For CID-103, an Anti-CD 38 Antibody in Antibody-Mediated Rejection, and Receipt of a Non-Binding Proposal to Acquire Entire China Business of the CompanyNASDAQ:CASICASI Pharmaceuticals Inc
2024/06/2705 : 10PR Newswire (US)CASI Pharmaceuticals Announces $15 Million Private Placement Financing by Venrock Healthcare Capital Partners, Foresite Capital, Panacea Venture and Dr. Wei-Wu HeNASDAQ:CASICASI Pharmaceuticals Inc
2024/05/1521 : 00PR Newswire (US)CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP)NASDAQ:CASICASI Pharmaceuticals Inc
2024/05/1519 : 50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CASICASI Pharmaceuticals Inc
2024/05/1421 : 00PR Newswire (US)CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2024 BUSINESS AND FINANCIAL RESULTSNASDAQ:CASICASI Pharmaceuticals Inc
2024/05/1313 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CASICASI Pharmaceuticals Inc
2024/04/0906 : 00PR Newswire (US)CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTASNASDAQ:CASICASI Pharmaceuticals Inc
2024/03/2820 : 00PR Newswire (US)CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTSNASDAQ:CASICASI Pharmaceuticals Inc
2024/03/0521 : 00PR Newswire (US)CASI Pharmaceuticals Report Positive Interim Phase 1 Data For BI-1206 In The Treatment Of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma In ChinaNASDAQ:CASICASI Pharmaceuticals Inc
2024/02/1621 : 00PR Newswire (US)CASI PHARMACEUTICALS ANNOUNCES FIRST DOSING OF FOLOTYN® IN CHINANASDAQ:CASICASI Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CASI

最近閲覧した銘柄

Delayed Upgrade Clock